I agree that this site is using cookies. You can find further informations here.
X
Récher, Christian
552  results:
Search for persons X
?
1

Guadecitabine vs TC in relapsed/refractory AML after intens..:

Roboz, Gail J. ; Sanz, Guillermo ; Griffiths, Elizabeth A....
Blood Advances.  8 (2024)  8 - p. 2020-2029 , 2024
Link: https://doi.org/10.1182/..
 
?
2

Outcomes of acute myeloid leukemia patients who responded t..:

Garciaz, Sylvain ; Dumas, Pierre‐Yves ; Bertoli, Sarah...
American Journal of Hematology.  , 2024
Link: https://doi.org/10.1002/..
 
?
3

Momelotinib versus Continued Ruxolitinib or Best Available ..:

Harrison, Claire N. ; Vannucchi, Alessandro M. ; Recher, Christian...
Advances in Therapy.  , 2024
Link: https://doi.org/10.1007/..
 
?
4

Dismal outcome of refractory or relapsing patients with mye..:

Leroy, Harmony ; Gadaud, Noémie ; Bérard, Emilie...
Cancer Medicine.  13 (2024)  3 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
5

Imatinib with intensive chemotherapy in AML with t(9;22)(q3..:

Gondran, Camille ; Dumas, Pierre-Yves ; Bérard, Emilie...
Blood Cancer Journal.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
6

Low frequency of Vγ9Vδ2 T-cells predicts poor survival in n..:

Le Floch, Anne CharlotteLe Floch ; Orlanducci, Florence ; Béné, Marie-Christine...
Blood Advances.  , 2024
Link: https://doi.org/10.1182/..
 
?
7

Differential prognostic values of the three AKT isoforms in..:

Corre, Eulalie ; Soum, Cécile ; Pfeifer, Romain...
Scientific Reports.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
8

Molecular relapse after first-line intensive therapy in pat..:

Orvain, Corentin ; Bertoli, Sarah ; Peterlin, Pierre...
Leukemia.  , 2024
Link: https://doi.org/10.1038/..
 
?
9

Artificial intelligence-based prediction models for acute m..:

Didi, Ibrahim ; Alliot, Jean-Marc ; Dumas, Pierre-Yves...
Leukemia Research.  136 (2024)  - p. 107437 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Long‐term follow‐up of VIALE‐A: Venetoclax and azacitidine ..:

Pratz, Keith W. ; Jonas, Brian A. ; Pullarkat, Vinod...
American Journal of Hematology.  99 (2024)  4 - p. 615-624 , 2024
Link: https://doi.org/10.1002/..
 
?
11

When acute promyelocytic leukaemia changes its face in the ..:

Le Grand, Sophie ; Canali, Alban ; Bertoli, Sarah...
eJHaem.  5 (2024)  3 - p. 635-637 , 2024
Link: https://doi.org/10.1002/..
 
?
12

POSTER: AML-469 Ivosidenib + Azacitidine vs Placebo + Azaci..:

de Botton, Stéphane ; Montesinos, Pau ; Polo, Susana Vives...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S166 , 2023
Link: https://doi.org/10.1016/..
 
?
13

AML-477 Real-World Treatment Patterns and Patient Character..:

Mehta, Priyanka ; Zeidner, Joshua ; Muluneh, Benyam...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S305 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Results from a phase I/II trial of cusatuzumab combined wit..:

Pabst, Thomas ; Vey, Norbert ; Adès, Lionel...
Haematologica.  108 (2023)  7 - p. 1793-1802 , 2023
Link: https://doi.org/10.3324/..
 
?
15

LSC17 score complements genetics and measurable residual di..:

Vasseur, Loïc ; Fenwarth, Laurène ; Lambert, Jérôme...
Blood Advances.  7 (2023)  15 - p. 4024-4034 , 2023
Link: https://doi.org/10.1182/..
 
1-15